SCHEMBL15480685

SCHEMBL15480685

Cc1ccc(-c2scc(NC(=O)c3cccc(F)c3)c2C(=O)O)s1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 6/20 0.54
KMT2A Q03164 6/20 0.54
POLB P06746 4/20 0.54
MAPT P10636 2/20 0.54
CRHBP P24387 1/20 0.54
CRHR2 Q13324 1/20 0.54
ALDH1A1 P00352 3/20 0.48
GAA P10253 1/20 0.48
ALOX15 P16050 1/20 0.48
TSHR P16473 1/20 0.48
KCNK3 O14649 2/20 0.45
SMN1; SMN2 Q16637 5/20 0.45
TDP1 Q9NUW8 1/20 0.45
L3MBTL1 Q9Y468 1/20 0.44
RAB9A P51151 3/20 0.44
KDM4E B2RXH2 3/20 0.44
NPC1 O15118 3/20 0.44
CYP1A2 P05177 3/20 0.44
CYP2C19 P33261 3/20 0.44
LMNA P02545 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1490346 0.83 MEN1 (0.50) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL12831298 0.82 SMN1; SMN2 (0.57) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL1490671 0.81 POLB (0.48) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL2181129 0.81 CASP3 (0.53) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL12831287 0.80 KDM4E (0.44) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL1490627 0.80 MEN1 (0.49) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL15480690 0.79 SMN1; SMN2 (0.49) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL1490500 0.78 MEN1 (0.50) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL1490367 0.78 MEN1 (0.50) MEN1KMT2APOLBMAPTCRHBP
SCHEMBL12830913 0.78 CYP1A2 (0.46) MEN1KMT2APOLBMAPTCRHBP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM CALCIMEDICA INC. (US) 2014-02-20 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140051711-A1 COMPOUNDS THAT MODULATE INTRACELLULAR CALCIUM ORAI1, SARAF, RYR2 MEN1 2958/4885KMT2A 4706/4885POLB 4774/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.